TheEdgeResearch
Home / Stocks / CVALF

Covalon Technologies Ltd. (CVALF)

OTC Healthcare Biotechnology
$1.67 ▲ +1.21%
Market Cap
$46.1M
Sector
Healthcare
Industry
Biotechnology
Beta
0.03
52-Wk Range
1.16-2.14
CEO
Brent Ashton
Country
CA
Currency
USD

Covalon Technologies Ltd. operates in the Biotechnology industry of the Healthcare sector, headquartered in Mississauga, ON, CA. The stock last traded at $1.67, up 1.21% on the session, giving a market capitalisation of $46.1M. On trailing twelve-month figures it carries a trailing P/E of 39.61, a net margin of 5.0%. Its beta of 0.03 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
39.61
Price / Sales
2.00
Price / Book
2.33
EV / EBITDA
24.17
Gross margin
53.0%
Operating margin
3.5%
Net margin
5.0%
Return on equity
Debt / equity
0.06
Current ratio
7.57
Dividend yield
6.3%
Payout ratio
252.3%
Company profile
Exchange
Other OTC
Employees
105
IPO date
2007-04-18
Headquarters
Mississauga, ON, CA
About Covalon Technologies Ltd.

Covalon Technologies Ltd. is a global medical technology firm specializing in the innovation, production, commercialization, and licensing of medical solutions across the United States, Canada, Europe, the Middle East, Asia, and Latin America. The company's operations are built upon three distinct proprietary technological platforms. The first, a collagen matrix platform, underpins a family of products aimed at treating chronic and infected wounds such as diabetic, pressure, and venous ulcers, as well as donor/graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first- and second-degree burns. Secondly, an antimicrobial silicone adhesive platform is utilized in various pre- and post-surgical and vascular access products, specifically engineered to eliminate bacteria or yeast on contact, thus providing broad-spectrum antimicrobial activity. The third is a medical coating platform, an advanced process employing photo-polymerization to create active grafting sites where new polymer chains are initiated and propagate from the surface of existing medical devices. Covalon's product offerings include wound care dressings, surgical and peri-operative solutions, and infection management tools. These products, sold under the Covalon brand, are distributed through both the company's direct sales force and third-party networks to a wide range of clients, including hospitals, wound and burn care centers, acute and extended care facilities, home health agencies, and physicians' offices. The company's corporate headquarters are located in Mississauga, Canada.

Comparable companies

Covalon Technologies Ltd. is most often compared with the following Healthcare names:

ACHFFCYYNFHBPCFINNMFMMIRFOTLCPSYBFRLFTFRLFTYSEOVF
More research on CVALF
CVALF technical analysis CVALF TheEdge Score Compare against peers
Open full interactive analysis & DCF →